U.S., Feb. 8 -- ClinicalTrials.gov registry received information related to the study (NCT06814769) titled 'Hyaluronic Acid and Articular Pain' on Jan. 31.
Brief Summary: This is a prospective longitudinal single-center clinical study on OA patients treated with HA . Patients will be enrolled at baseline (T0) and then monitored at 90 days (T1), 180 days (T2; ), and 360 days (T3). The first efficacy end-point will be the statistically significant difference (P<0.05) in VAS scale between T2 and T0 and between T3 and T2
Study Start Date: Jan. 15, 2023
Study Type: OBSERVATIONAL
Condition:
Osteoarthritis
Intervention:
DEVICE: hyaluronic acid
intra-articular administration
Recruitment Status: COMPLETED
Sponsor: University of Catanzaro
...